NVTA Stock Recent News
NVTA LATEST HEADLINES
After taking a beating last year, is now the time to load up on these stocks?
The bears have prevailed with Invitae this year. But could the future be better for the beaten-down stock?
Is Vertex worth its lofty valuation compared to Invitae?
The company's cash burn is improving, but it's still troubling.
Investors continue to be encouraged by the company's cost-cutting attempts.
Both of these stocks have dropped more than 70% this year.
Hot penny stocks to watch after October's CPI report. The post Best Penny Stocks To Buy Now That CPI Is Out?
The medical genetics company beat expectations with its Q3 results.
Invitae (NVTA) delivered earnings and revenue surprises of 28.81% and 0.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Even though the genetics testing specialist didn't divulge the financial details of a new partnership, investors nevertheless were happpy about the news.